Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Electroencephalogram (EEG) abnormalities can be a side effect of certain antidepressant medications.
• Understanding these effects is crucial for patient safety and treatment optimization.

Purpose of the Study:

• To compare the incidence of antidepressant-induced EEG abnormalities between amitriptyline and bupropion in depressed inpatients.
• To investigate the relationship between plasma drug concentrations and EEG changes.

Main Methods:

• A double-blind study involving 34 randomly assigned depressed inpatients.
• Baseline and follow-up EEGs were recorded under steady-state pharmacokinetic conditions.
• EEG abnormalities were assessed and compared between patients treated with amitriptyline and bupropion.

Main Results:

• Eight out of 34 patients developed EEG abnormalities.
• Seven patients on amitriptyline showed EEG abnormalities, compared to only one patient on bupropion (p < 0.01).
• Amitriptyline-induced EEG abnormalities were associated with plasma concentrations above the therapeutic range (150-250 ng/ml).

Conclusions:

• Amitriptyline is associated with a significantly higher risk of inducing EEG abnormalities compared to bupropion.
• The occurrence of amitriptyline-induced EEG abnormalities appears to be related to plasma drug levels exceeding the therapeutic range.